Omalizumab had the greatest risk for adverse effects and dupilumab had the most favorable safety profile among biologics for patients with asthma, according to an abstract presented at the CHEST ...
In patients with moderate-to-severe allergic asthma, tezepelumab yields the greatest reduction in exacerbations among biologics compared with placebo.
An anti-inflammation injectable drug called dupilumab can reduce mucus buildup and improve breathing among asthma patients, a ...
Patients who depended on oral corticosteroids to care for their severe asthma experienced improvements in asthma control ...
Medpage Today on MSN
Regulatory T-Cell Drug Promising for Eczema, With Hint for Asthma as Well
For the primary endpoint, Eczema Area and Severity Index (EASI) improved by 53-61% in a dose-dependent manner across the ...
Down-titrating vial concentrations when restarting subcutaneous allergen immunotherapy after treatment gaps may help lower ...
We've nearly made it through a wet and windy Wednesday, which will be good practice for more of the same tomorrow! Seattle Public Schools names Ben Shuldiner superintendent finalist after nationwide ...
OKLAHOMA CITY (KFOR) — Next month, Oklahomans with severe asthma who are insured with BlueCross and BlueShield of Oklahoma (BCBSOK), may have to give themselves life-saving shots at home after a ...
Hosted on MSN
Oklahoma's largest health insurer is putting its own profits ahead of patients | Opinion
Oklahoma's largest health insurer recently made a drastic change that will limit treatment options for people battling severe asthma.Blue Cross Blue Shield of Oklahoma, which covers more than 800,000 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback